ClinicalTrials.gov
ClinicalTrials.gov Menu

Effects of Metreleptin in Type 1 Diabetes Mellitus

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01268644
Recruitment Status : Terminated (Sponsor request)
First Posted : December 31, 2010
Last Update Posted : May 4, 2016
Sponsor:
Collaborators:
Juvenile Diabetes Research Foundation
Amylin Pharmaceuticals, LLC.
Information provided by (Responsible Party):
Abhimanyu Garg, University of Texas Southwestern Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : January 2013
  Actual Study Completion Date : August 2014